Language
FDA approves surgical robot device from USMI

News

HomeHome / News / FDA approves surgical robot device from USMI
search
RECENT NEWS

Aug 18, 2023

Inspire Medical appoints Charisse Sparks as chief medical officer

Aug 14, 2023

Revolutionizing Mobility: Exploring the Orthopedic Prosthetic Devices Market is projected to register a CAGR of 4.7% by 2032

Aug 20, 2023

Surgical Power Tools Professional Market 2031 Key Insights and Leading Players Aygun Surgical Instruments, MedicMicro, Anthrax, Adeor Medical, Gordian Surgical, OsteoMed, etc

Aug 10, 2023

Psychometric properties and validation of the polish version of the Fibromyalgia Impact Questionnaire (FIQ

Aug 16, 2023

Stryker surpasses Q2 forecasts, boosts full

SEND YOUR INQUIRY
SUBMIT

Apr 18, 2024

FDA approves surgical robot device from USMI

June 30, 2023 By Sean Whooley US Medical Innovations (USMI) received FDA approval for its Canady Flex RoboWrist for use in open and laparoscopic procedures. The surgical robot system already has

June 30, 2023 By Sean Whooley

US Medical Innovations (USMI) received FDA approval for its Canady Flex RoboWrist for use in open and laparoscopic procedures.

The surgical robot system already has approval in the Middle East, Europe and Asia.

Takoma Park, Maryland-based USMI designed the Flex RoboWrist as a fully articulating, 5 mm handheld surgical instrument. It features a variety of end effectors, including a hook, scissors, needle driver and dissector. The system offers three degrees of freedom and 360 degrees of rotation.

USMI said it includes a connector for its XL-1000 electrosurgical generator, too. This allows the option of using the mono scissors or hook for electrosurgery. The company said it designed the device primarily for dissection, transection and/or suturing of tissue during open, endoscopic and minimally invasive surgical procedures. These include laparoscopic, urologic, gynecologic, general and thoracic surgeries.

Key features include precision and accuracy, with precise movements reducing the risk of human error and enhancing surgical outcomes. Flex RoboWrist comes with state-of-the-art automation and intelligent control systems to optimize workflows and save time in the OR.

USMI said the cost-effective options eliminate the need to use disposables, too.

“The Flex RoboWrist represents a significant advancement in laparoscopic surgical technology and will empower surgeons to achieve exceptional results and redefine the possibilities of laparoscopic surgical procedures,” said Dr. Jerome Canady, CEO of USMI. “The flexible design provides motorized control of two movements that are essential to accessing surgical sites and laparoscopic suturing: bidirectional deflection and unlimited rotation of the distal jaws of the instrument.”

Filed Under: Food & Drug Administration (FDA), Health Technology, Regulatory/Compliance, Robotics, Surgical Tagged With: FDA, USMI